BRPI0912769A2 - anticorpos anti-pirb - Google Patents
anticorpos anti-pirbInfo
- Publication number
- BRPI0912769A2 BRPI0912769A2 BRPI0912769A BRPI0912769A BRPI0912769A2 BR PI0912769 A2 BRPI0912769 A2 BR PI0912769A2 BR PI0912769 A BRPI0912769 A BR PI0912769A BR PI0912769 A BRPI0912769 A BR PI0912769A BR PI0912769 A2 BRPI0912769 A2 BR PI0912769A2
- Authority
- BR
- Brazil
- Prior art keywords
- pirb
- antibodies
- pirb antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5294908P | 2008-05-13 | 2008-05-13 | |
US12/208,883 US20100047232A1 (en) | 2006-11-14 | 2008-09-11 | Modulators of neuronal regeneration |
US12/316,130 US20090232794A1 (en) | 2007-12-11 | 2008-12-09 | Modulators of neuronal regeneration |
PCT/US2009/043757 WO2009140361A1 (en) | 2008-05-13 | 2009-05-13 | ANTI-PirB ANTIBODIES |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0912769A2 true BRPI0912769A2 (pt) | 2015-10-13 |
Family
ID=41319035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0912769A BRPI0912769A2 (pt) | 2008-05-13 | 2009-05-13 | anticorpos anti-pirb |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP2291405A1 (pt) |
JP (1) | JP2011523359A (pt) |
KR (1) | KR20110011676A (pt) |
CN (1) | CN102089327A (pt) |
AR (1) | AR071777A1 (pt) |
AU (1) | AU2009246443A1 (pt) |
BR (1) | BRPI0912769A2 (pt) |
CA (1) | CA2723430A1 (pt) |
IL (1) | IL209129A0 (pt) |
MX (1) | MX2010012299A (pt) |
PE (1) | PE20091969A1 (pt) |
RU (1) | RU2010150754A (pt) |
TW (1) | TW200950808A (pt) |
WO (1) | WO2009140361A1 (pt) |
ZA (1) | ZA201007976B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011091177A1 (en) | 2010-01-20 | 2011-07-28 | Tolerx, Inc. | Anti-ilt5 antibodies and ilt5-binding antibody fragments |
WO2011091181A1 (en) | 2010-01-20 | 2011-07-28 | Tolerx, Inc. | Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments |
IN2014MN02274A (pt) * | 2012-04-17 | 2015-08-07 | Mayo Foundation | |
CN103130898B (zh) * | 2013-01-28 | 2014-03-26 | 中国人民解放军第四军医大学 | Tat-lbd-pep融合蛋白及其在治疗中枢神经系统损伤疾病中的应用 |
EP4219559A3 (en) | 2017-12-22 | 2023-10-18 | Jounce Therapeutics, Inc. | Antibodies for lilrb2 |
PE20211604A1 (es) | 2018-07-09 | 2021-08-23 | Five Prime Therapeutics Inc | Anticuerpos de union a ilt4 |
CN109439661B (zh) * | 2018-10-22 | 2020-10-23 | 西安医学院 | 抑制pirB表达的短发卡shRNA、慢病毒及其应用 |
MX2022013466A (es) | 2020-05-01 | 2022-11-16 | Ngm Biopharmaceuticals Inc | Agentes de union a ilt y metodos para su uso. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2466118A1 (en) * | 2001-11-14 | 2003-05-22 | Immunex Corporation | Modulation of lir function to treat rheumatoid arthritis |
CA2637786A1 (en) * | 2006-01-23 | 2007-08-16 | President And Fellows Of Harvard College | Compositions and methods for enhancing neuronal plasticity and regeneration |
-
2009
- 2009-05-13 EP EP09747445A patent/EP2291405A1/en not_active Withdrawn
- 2009-05-13 RU RU2010150754/10A patent/RU2010150754A/ru not_active Application Discontinuation
- 2009-05-13 CN CN2009801265242A patent/CN102089327A/zh active Pending
- 2009-05-13 AR ARP090101723A patent/AR071777A1/es not_active Application Discontinuation
- 2009-05-13 PE PE2009000673A patent/PE20091969A1/es not_active Application Discontinuation
- 2009-05-13 BR BRPI0912769A patent/BRPI0912769A2/pt not_active IP Right Cessation
- 2009-05-13 WO PCT/US2009/043757 patent/WO2009140361A1/en active Application Filing
- 2009-05-13 CA CA2723430A patent/CA2723430A1/en not_active Abandoned
- 2009-05-13 MX MX2010012299A patent/MX2010012299A/es active IP Right Grant
- 2009-05-13 KR KR1020107027786A patent/KR20110011676A/ko not_active Application Discontinuation
- 2009-05-13 JP JP2011509642A patent/JP2011523359A/ja active Pending
- 2009-05-13 AU AU2009246443A patent/AU2009246443A1/en not_active Abandoned
- 2009-05-13 TW TW098115945A patent/TW200950808A/zh unknown
-
2010
- 2010-11-04 IL IL209129A patent/IL209129A0/en unknown
- 2010-11-08 ZA ZA2010/07976A patent/ZA201007976B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20110011676A (ko) | 2011-02-08 |
RU2010150754A (ru) | 2012-06-20 |
ZA201007976B (en) | 2012-02-29 |
CA2723430A1 (en) | 2009-11-19 |
AU2009246443A1 (en) | 2009-11-19 |
JP2011523359A (ja) | 2011-08-11 |
TW200950808A (en) | 2009-12-16 |
CN102089327A (zh) | 2011-06-08 |
PE20091969A1 (es) | 2010-01-15 |
WO2009140361A1 (en) | 2009-11-19 |
IL209129A0 (en) | 2011-01-31 |
AR071777A1 (es) | 2010-07-14 |
EP2291405A1 (en) | 2011-03-09 |
MX2010012299A (es) | 2010-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2019004I1 (el) | Τροποποιημενα αντισωματα αντι-ιl-23ρ19 | |
BRPI0906877A2 (pt) | Anticorpos anti-trkb aperfeiçoados | |
BRPI0907237A2 (pt) | Anticorpo anti-cldn6 | |
BRPI0917148A2 (pt) | anticorpos anti-cd5 | |
BRPI0912173A2 (pt) | anticorpos anti-flt3 | |
BRPI0923359A2 (pt) | Anticorpos anti-igf | |
BRPI0922800A2 (pt) | anticorpos c-met | |
BRPI0907532A2 (pt) | Anticorpos anti-c5ar humanizados | |
DK2370462T3 (da) | Glucagon-analoger | |
BRPI0907376A2 (pt) | Fotobiorretador | |
DK2342317T3 (da) | Hængende-dråbe-plade | |
DE602009000234D1 (de) | msignals | |
BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
DE602008003972D1 (de) | Sitzrücklehnungsmechanismus | |
DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
DK2336132T3 (da) | Morpholinpurinderivat | |
DK2342454T3 (da) | Vindkraftanlæg | |
DK2335031T3 (da) | In-line-måler | |
BRPI0909633A2 (pt) | anticorpos anti-tyrp1 | |
BRPI0817427A2 (pt) | Anticorpo anti-bst2 | |
DE602008003970D1 (de) | Strahlstromkalibriersystem | |
DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
BRPI0907522A2 (pt) | biarlamidas | |
DE112009001946A5 (de) | Mobelauszugsführung | |
DE602009000488D1 (de) | Obstvereinzelvorrichtung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |